|
CN106834252A
|
|
A kind of high stable type MazF mutant and its application
|
|
CN106806352A
|
|
It is a kind of to be sustained, target the Nano medication for being applied to nerve degenerative diseases
|
|
CN106757377A
|
|
A kind of aptamers combinatorial libraries, its construction method and purposes
|
|
CN106562966A
|
|
Application of compound in resisting post-traumatic stress disorders
|
|
CN106397669A
|
|
Cyanoacrylate material capable of producing fluorescence
|
|
CN106397522A
|
|
3,7-di(t-butyldimethylsiloxy)-6-ene-5beta-cholan-24-oic acid methyl ester
|
|
CN105994086A
|
|
Controllable zebra fish behavior testing system capable of simulating live action by projection
|
|
CN106256833A
|
|
The method preparing 3,7 2 (the silica-based epoxide of trimethyl) 6 alkene 5 β cholane 24 acid methyl ester
|
|
CN105561378A
|
|
Cyanoacrylate material capable of releasing oxygen gas
|
|
CN105393933A
|
|
Non-human primate animal reaction behavior testing system
|
|
CN105533863A
|
|
Non-human primate animal protector
|
|
CN105361971A
|
|
Fixing chair for nonhuman primate
|
|
CN105393926A
|
|
Non-human primate animal self-drug delivery system operation box
|
|
CN106866433A
|
|
Fragrant 2- butanol chirality class compound, asymmetric syntheses and its medical usage
|
|
CN106810509A
|
|
A kind of 4- oxos -4,5- thiazolines analog derivative, Preparation Method And The Use
|
|
CN106749033A
|
|
Hydantoin compounds and its purposes as beta-secretase inhibitor
|
|
CN106552268A
|
|
Targeting CNT delivery system, Preparation Method And The Use
|
|
CN106518848A
|
|
Novel chromene diarylurea compounds, and preparation method and application thereof
|
|
CN106518858A
|
|
Substituted benzothiazole diaryl urea compounds, and preparation method and medical application thereof
|
|
CN106518766A
|
|
Novel diaryl urea compounds, and preparation method and medical applications thereof
|
